- Home
- CTNM vs HBCP Comparison
CTNM vs HBCP Comparison
Compare CTNM & HBCP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTNM
- HBCP
- Stock Information
- Founded
- CTNM 2009
- HBCP 1908
- Country
- CTNM United States
- HBCP United States
- Employees
- CTNM N/A
- HBCP N/A
- Industry
- CTNM
- HBCP Banks
- Sector
- CTNM
- HBCP Finance
- Exchange
- CTNM Nasdaq
- HBCP Nasdaq
- Market Cap
- CTNM 453.0M
- HBCP 398.8M
- IPO Year
- CTNM 2024
- HBCP 2008
- Fundamental
- Price
- CTNM $17.21
- HBCP $49.38
- Analyst Decision
- CTNM Strong Buy
- HBCP Buy
- Analyst Count
- CTNM 4
- HBCP 2
- Target Price
- CTNM $29.25
- HBCP $46.50
- AVG Volume (30 Days)
- CTNM 74.8K
- HBCP 31.0K
- Earning Date
- CTNM 11-06-2024
- HBCP 10-17-2024
- Dividend Yield
- CTNM N/A
- HBCP 2.11%
- EPS Growth
- CTNM N/A
- HBCP N/A
- EPS
- CTNM N/A
- HBCP 4.51
- Revenue
- CTNM N/A
- HBCP $130,219,000.00
- Revenue This Year
- CTNM N/A
- HBCP N/A
- Revenue Next Year
- CTNM N/A
- HBCP $4.36
- P/E Ratio
- CTNM N/A
- HBCP $10.95
- Revenue Growth
- CTNM N/A
- HBCP N/A
- 52 Week Low
- CTNM $13.27
- HBCP $33.30
- 52 Week High
- CTNM $22.00
- HBCP $52.39
- Technical
- Relative Strength Index (RSI)
- CTNM N/A
- HBCP 58.93
- Support Level
- CTNM N/A
- HBCP $50.18
- Resistance Level
- CTNM N/A
- HBCP $52.02
- Average True Range (ATR)
- CTNM 0.00
- HBCP 1.86
- MACD
- CTNM 0.00
- HBCP 0.06
- Stochastic Oscillator
- CTNM 0.00
- HBCP 57.72
About CTNM Contineum Therapeutics Inc. Class A Common Stock
Contineum Therapeutics Inc is a clinical stage biopharmaceutical company focused on discovering and developing novel, oral small molecule therapies for NI&I indications with high unmet need. Its internally-discovered drug candidates, PIPE-791 and PIPE-307, PIPE-791, is a novel, brain penetrant, small molecule inhibitor of the LPA1R in development for IPF and PIPE-307, is a novel, small molecule selective inhibitor of the muscarinic type 1 M1R, in development for depression and RRMS.
About HBCP Home Bancorp Inc.
Home Bancorp Inc is engaged in attracting deposits from the public and using those funds to invest in loans and securities. The principal sources of funds are customer deposits, repayments of loans, repayments of investments and funds borrowed from outside sources such as the Federal Home Loan Bank of Dallas. These funds are used for the origination of loans, including one-to-four-family first mortgage loans, home equity loans, and lines, commercial real estate loans, construction and land loans, multi-family residential loans, commercial and industrial loans, and consumer loans. Its primary expenses are interest expense on deposits and borrowings and general operating expenses.